Hudson Bay Capital Management LP Iovance Biotherapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 135,000 shares of IOVA stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
135,000
Previous 250,000
46.0%
Holding current value
$1.05 Million
Previous $2.01 Million
36.81%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding IOVA
# of Institutions
314Shares Held
241MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$213 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$208 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$187 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$103 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.23B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...